FOR RESEARCH & LABORATORY USE ONLY. NOT FOR HUMAN CONSUMPTION. DO NOT SELF-ADMINISTER.
🧬 Triple Agonist

Retatrutide Reconstitution

Specialized calculator for the GIP/GLP-1/Glucagon receptor agonist (LY3437943). Investigational use only.

🧪 10mg Standard Vial
⚖️ 2-4mg Starting
Engine v2.0

Mixing Parameters

MG
mL
0.5ml 2.0ml 5.0ml

Required Target Dose (Retatrutide)

mcg
Concentration
0
mcg per 1 mL
Per Syringe Tick
0
mcg per unit
Final Volume to Pull
0 Units

Draw the liquid to the mark on your syringe.

Retatrutide Calculation Breakdown

  • 01

    Retatrutide Vial (mg) converts to:

  • 02

    Mixed with mL bacteriostatic water creates: solution

  • 03

    To get mcg, you need units on the syringe.

Understanding Retatrutide (LY3437943)

Retatrutide is a novel investigational peptide that acts as a triple agonist, targeting the receptors for GIP (glucose-dependent insulinotropic polypeptide), GLP-1 (glucagon-like peptide-1), and Glucagon. This "Triple G" mechanism is currently being studied for its potential in significant weight management and metabolic health improvement.

Research Use Only: Retatrutide is an investigational compound not yet approved by the FDA. The information below reflects protocols observed in clinical studies (e.g., TRIUMPH-1) and is for educational research purposes only.

Common Research Titration Schedule

Clinical trials typically follow a monthly escalation schedule to mitigate gastrointestinal side effects.

Phase Weekly Dose Duration
Initiation 2 mg 4 Weeks
Step 1 4 mg 4 Weeks
Step 2 8 mg 4 Weeks
Maintenance (Max) 12 mg Indefinite

Stability & Storage

  • Reconstituted: Stable for 3-4 weeks when stored at 2°C to 8°C (Refrigerator). Do not freeze after mixing.
  • Lyophilized (Powder): Stable for up to 2 years at -20°C (Freezer).

Retatrutide 10mg Reconstitution Chart

Based on standard 10mg Vial + 2mL Bacteriostatic Water

Desired Dose Unit Pull (U-100) mL Volume
1 mg (1000 mcg) 20 Units 0.20 mL
2 mg (2000 mcg) 40 Units 0.40 mL
4 mg (4000 mcg) 80 Units 0.80 mL
8 mg (8000 mcg) 160 Units (1.6 syringes) 1.60 mL
Clinical Review
Dr. Igor I. Bussel
Dr. Igor I. Bussel, MD
Board-Certified Ophthalmologist

Dr. Igor I. Bussel is a board-certified ophthalmologist and fellowship-trained surgeon affiliated with the University of California, Irvine (UCI), the Gavin Herbert Eye Institute, and the UCI School of Medicine.

Sources & Guidelines
Pediatrics Veterinary Edibles Peptides Chemicals Microdose